Endogenous Hydrogen Sulfide Regulates Pulmonary Artery Collagen Remodeling in Rats with High Pulmonary Blood Flow

Abstract

The mechanisms responsible for the structural remodeling of pulmonary vasculature induced by increased pulmonary blood flow are not fully understood. This study explores the effect of endogenous hydrogen sulfide (H₂S), a novel gasotransmitter, on collagen remodeling of the pulmonary artery in rats with high pulmonary blood flow. Thirty-two Sprague-Dawley rats were randomly divided into sham, shunt, sham+PPG (D,L-propargylglycine, an inhibitor of cystathionine-γ-lyase), and shunt+PPG groups. After 4 weeks of shunting, the relative medial thickness (RMT) of pulmonary arteries and H₂S concentration in lung tissues were investigated. Collagen I and collagen III were evaluated by hydroxyproline assay, sirius-red staining, and immunohistochemistry. Pulmonary artery matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and connective tissue growth factor (CTGF) were evaluated by immunohistochemistry. After 4 weeks of aortocaval shunting, resulting in an elevation of lung tissue H₂S to 116.4%, rats exhibited collagen remodeling and increased CTGF expression in the pulmonary arteries. Compared with those of the shunt group, lung tissue H₂S production was lowered by 23.4%, RMT of the pulmonary artery further increased by 39.5%, pulmonary artery collagen accumulation became obvious, and pulmonary artery CTGF expression elevated (P < 0.01) in the shunted rats treated with PPG. However, pulmonary artery MMP-13 and TIMP-1 expressions decreased significantly in rats of shunt+PPG group (P < 0.01). This study suggests that endogenous H₂S exerts an important regulatory effect on pulmonary collagen remodeling induced by high pulmonary blood flow.

Get full access to this article

View all access options for this article.

References

Du J, Hui Y, Cheung Y, Bin G, Jiang H, Chen X, Tang C. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 19:75–80, 2004.

Pearson RJ, Wilson T, Wang R. Endogenous hydrogen sulfide and the cardiovascular system-what’s the smell all about? Clin Invest Med 29: 146–150, 2006.

Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 5:493–501, 2003.

Xiaohui L, Junbao D, Lin S, Jian L, Xiuying T, Jianguang Q, Bing W, Hongfang J, Chaoshu T. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ J 69:1418–1424, 2005.

Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J20:6008–6016, 2001.

Garcia R, Diebold S. Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 24:430–432, 1990.

Ocampo C, Ingram P, Ilbawi M, Arcilla R, Gupta M. Revisiting the surgical creation of volume load by aorto-caval shunt in rats. Mol Cell Biochem 251:139–143, 2003.

Yan H, Du J, Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 313:22–27, 2004.

Barth PJ, Kimpel C, Roy S, Wagner U. An improved mathematical approach for the assessment of the medial thickness of pulmonary arteries. Pathol Res Pract 189:567–76, 1993.

10.

Stipanuk MH, Beck PW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 206:267–277, 1982.

11.

Erickson PF, Maxwell IH, Su LJ, Baumann M, Glode LM. Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes. Biochem J 269:335–340, 1990.

12.

Zhong G, Chen F, Cheng Y, Tang C, Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 21:1879–1885, 2003.

13.

Chunyu Z, Junbao D, Dingfang B, Hui Y, Xiuying T, Chaoshu T. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 302:810–816, 2003.

14.

Hui Y, Du J, Tang C, Bin G, Jiang H. Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats. J Infect 47:155–160, 2003.

15.

Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, Du J, Tang C. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 318:756–763, 2004.

16.

Chen CQ, Xin H, Zhu YZ. Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential. Acta Pharmacol Sin 28:1709–1716, 2007.

17.

Abeles RH, Walsh CT. Acetylenic enzyme inactivators. Inactivation of gamma-cystathionase, in vitro and in vivo, by propargylglycine. J Am Chem Soc 95: 6124–6125, 1973.

18.

Marcotte P, Walsh C. Active site-directed inactivation of cystathionine gamma-synthetase and glutamic pyruvic transaminase by propargylglycine. Biochem Biophys Res Commun 62:677–682, 1975.

19.

Johnston M, Jankowski D, Marcotte P, Tanaka H, Esaki N, Soda K, Walsh C. Suicide inactivation of bacterial cystathionine gamma-synthase and methionine gamma-lyase during processing of L-propargylglycine. Biochemistry 18:4690–4701, 1979.

20.

Zhang J, Machida Y, Sugahara K, Kodama H. Determination of D,L-propargylglycine and N-acetylpropargylglycine in urine and several tissues of D,L-propargylglycine-treated rats using liquid chromatography-mass spectrometry. J Chromatogr B Biomed Appl 660:375–379, 1994.

21.

Kodama H, Mikasa H, Sasaki K, Awata S, Nakayama K. Unusual metabolism of sulfur-containing amino acids in rats treated with DL-propargylglycine. Arch Biochem Biophys 225:25–32, 1983.

22.

Li XH, Bu DF, Jin HF, Ding YG, Du JB, Li J, Tang CS. The dynamic changes in endogenous hydrogen sulfide pathway at the early stage of pulmonary hypertension induced by high pulmonary flow in rats. Chin J Appl Physiol 23:75–79, 2007.

23.

Zhang CY, Du JB, Yan H, Tang CS. Effect of a new gasotransmitter, hydrogen sulfide, on collagen remodeling of pulmonary artery under hypoxia. Zhonghua Jie He He Hu Xi Za Zhi 28:448–452, 2005.

24.

Edwards GA, Orien WD. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 104:161–167, 1980.

25.

Pérez-Ramos J, Lourdes Segura-Valdez M, Vanda B, Selman M, Pardo A. Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. Am J Respir Crit Care Med 160:1274–1282,1999.

26.

Ruiz V, Ordóñez RM, Berumen J, Ramírez R, Uhal B, Becerril C, Pardo A, Selman M. Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 285:1026–1036, 2003.

27.

Twigg SM, Joly AH, Chen MM, Tsubaki J, Kim HS, Hwa V, Oh Y, Rosenfeld RG. Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. Endocrinology 143:1260–1269, 2002.

28.

Schild C, Trueb B. Mechanical stress is required for high-level expression of connective tissue growth factor. Exp Cell Res 274:83–91, 2002.

29.

Kessler D, Dethlefsen S, Haase I, Plomann M, Hirche F, Krieg T, Eckes B. Fibroblasts in mechanically stressed collagen lattices assume a “synthetic” phenotype. J Biol Chem 276:36575–36585, 2001.